Ron Bentsur
2017 - UroGen Pharma Ltd.
In 2017, Ron Bentsur earned a total compensation of $2M as Former Chief Executive Officer at UroGen Pharma Ltd., a 394% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,973 |
|---|---|
| Option Awards | $1,244,448 |
| Salary | $414,252 |
| Other | $87,667 |
| Total | $1,972,339 |
Bentsur received $1.2M in option awards, accounting for 63% of the total pay in 2017.
Bentsur also received $226K in non-equity incentive plan, $414.3K in salary and $87.7K in other compensation.
Rankings
In 2017, Ron Bentsur's compensation ranked 5,565th out of 14,666 executives tracked by ExecPay. In other words, Bentsur earned more than 62.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,565 out of 14,666 | 62nd |
Division Manufacturing | 2,013 out of 5,768 | 65th |
Major group Chemicals And Allied Products | 618 out of 2,074 | 70th |
Industry group Drugs | 475 out of 1,730 | 73rd |
Industry Pharmaceutical Preparations | 372 out of 1,329 | 72nd |
Source: SEC filing on April 26, 2019.
Bentsur's colleagues
We found three more compensation records of executives who worked with Ron Bentsur at UroGen Pharma Ltd. in 2017.